The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy.
Takaura K, Kurosaki M, Inada K, Kirino S, Yamashita K, Muto T, Osawa L, Sekiguchi S, Hayakawa Y, Higuchi M, Kaneko S, Maeyashiki C, Tamaki N, Yasui Y, Itakura J, Tsuchiya K, Nakanishi H, Takahashi Y, Izumi N.
Takaura K, et al. Among authors: nakanishi h.
PLoS One. 2022 Feb 23;17(2):e0264075. doi: 10.1371/journal.pone.0264075. eCollection 2022.
PLoS One. 2022.
PMID: 35196341
Free PMC article.